 |
|
|
| |
Pre-Exposure Prophylaxis Product Choice in United States Participants in HPTN 083
|
| |
| |
CROI 2023 Feb 20-23
Meredith E. Clement1, Zhe Wang2, Carl Fichternbaum3, Schuyler Thomas4, Jose A. Bazan5, Paul Richardson6, Matthew A. Spinelli7, Brett Hanscom2, Alex Rinehart8, Jim Rooney9, Adeola Adeyeye10,
Marybeth McCauley11, Myron S. Cohen12, Beatriz Grinsztejn13, Raphael J. Landovitz14
1Louisiana State University Health Sciences Center, New Orleans, LA, USA, 2Fred Hutchinson Cancer Research Center, Seattle, WA USA, 3University of Cincinnati, Cincinnati, OH, USA, 4University of California Los Angeles, Los Angeles, CA, USA, 5The Ohio State University, Columbus, OH, USA, 6The Johns Hopkins University School of Medicine, Baltimore, MD, USA, 7University of California San Francisco, San Francisco, CA, USA, 8ViiV Healthcare, Durham, NC, USA 9Gilead Sciences, Inc, Foster City, CA, USA 10Centers for Disease Control and Prevention, 11FHI 360, Washington, DC, USA 12University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 13Institute de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil 14UCLA Center for Clinical AIDS Research & Education, University of California Los Angeles, Los Angeles, CA, USA
|
| |
|
|
|
|
|
